U.S. market Closed. Opens in 9 hours 57 minutes

ICVX | Icosavax, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2022-12-312021-12-312020-12-312019-12-31
Revenue582.00K7.80M1.62MN/A
Cost of Revenue1.84M82.00K17.67M4.16M
Gross Profit-1.26M7.72M-16.05M-4.16M
Operating Expenses95.06M65.86M18.71M5.40M
Selling, General & Admin30.23M34.89M2.66M1.24M
Research & Development65.41M38.78M17.67M4.16M
Other Operating Expenses-582.00K-7.80M-1.62MN/A
Operating Income-95.06M-65.86M-18.71M-5.40M
Other Expenses / Income3.30M-1.11M-144.00K101.00K
Before Tax Income-91.76M-66.97M-18.85M-5.30M
Income Tax Expenses-3.30M1.03M331.00K-101.00K
Net Income-88.46M-68.00M-19.18M-5.20M
Interest Expenses-3.30M151.00K331.00KN/A
Basic Shares Outstanding39.73M17.97M2.88M10.24M
Diluted Shares Outstanding39.73M17.97M2.88M10.24M
EBITDA-95.06M-64.90M-18.71M-5.40M
EBITDA Margin-16,332.99%-831.86%-1,157.74%0.00%
EBIT-95.06M-66.82M-18.52M-5.30M
EBIT Margin-16,332.99%-856.45%-1,146.23%0.00%
Financial Year End2022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙